Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy.
作者信息
Ge Junbo
机构信息
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
出版信息
Cardiol J. 2020;27(1):97-98. doi: 10.5603/CJ.2020.0023.
Abstract
摘要
相似文献
1
Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy.
Cardiol J. 2020;27(1):97-98. doi: 10.5603/CJ.2020.0023.
2
Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.
Trends Cardiovasc Med. 2018 Aug;28(6):392-400. doi: 10.1016/j.tcm.2018.01.001. Epub 2018 Jan 9.
3
Generalizability and Implications of the HFPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction.
Circulation. 2019 Apr 9;139(15):1851-1853. doi: 10.1161/CIRCULATIONAHA.118.039051.
4
Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction.
Circulation. 2017 Apr 4;135(14):1279-1280. doi: 10.1161/CIRCULATIONAHA.117.027324.
5
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2016 Jan 25;5(1):e002477. doi: 10.1161/JAHA.115.002477.
6
Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community.
Eur J Prev Cardiol. 2019 Apr;26(6):613-623. doi: 10.1177/2047487318816774. Epub 2018 Nov 27.
7
Benchmarking pre-clinical heart failure with preserved ejection fraction models: can we do better?
Cardiovasc Res. 2024 May 7;120(6):e20-e21. doi: 10.1093/cvr/cvae059.
8
[Heart failure with preserved ejection fraction (HFpEF)].
Ther Umsch. 2018 Sep;75(3):161-169. doi: 10.1024/0040-5930/a000983.
9
New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion?
Sultan Qaboos Univ Med J. 2017 Feb;17(1):e23-e26. doi: 10.18295/squmj.2016.17.01.005. Epub 2017 Mar 30.
10
New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure.
Arch Cardiovasc Dis. 2017 Jan;110(1):1-6. doi: 10.1016/j.acvd.2016.12.001. Epub 2017 Jan 9.
引用本文的文献
1
Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies.
BMJ Open. 2025 Aug 1;15(7):e093306. doi: 10.1136/bmjopen-2024-093306.
2
Nitazoxanide protects against heart failure with preserved ejection and metabolic syndrome induced by high-fat diet (HFD) plus L-NAME "two-hit" in mice.
Acta Pharm Sin B. 2025 Mar;15(3):1397-1414. doi: 10.1016/j.apsb.2024.12.040. Epub 2025 Jan 4.
3
The prognostic value of HFA-PEFF score in connective tissue disease-associated PAH: evidence from a cohort study.
BMC Cardiovasc Disord. 2025 Apr 5;25(1):258. doi: 10.1186/s12872-025-04691-y.
4
Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction.
Rev Cardiovasc Med. 2023 Sep 25;24(9):274. doi: 10.31083/j.rcm2409274. eCollection 2023 Sep.
5
Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study.
Sci Rep. 2024 May 17;14(1):11333. doi: 10.1038/s41598-024-61480-x.
6
Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction.
Europace. 2023 Dec 28;26(1). doi: 10.1093/europace/euad363.
7
Clinical Usefulness of Speckle-Tracking Echocardiography in Patients with Heart Failure with Preserved Ejection Fraction.
Diagnostics (Basel). 2023 Sep 12;13(18):2923. doi: 10.3390/diagnostics13182923.
8
Phenotypes of Cardiovascular Diseases: Current Status and Future Perspectives.
Phenomics. 2021 Aug 26;1(5):229-241. doi: 10.1007/s43657-021-00022-1. eCollection 2021 Oct.
9
Sex differences and related estrogenic effects in heart failure with preserved ejection fraction.
Heart Fail Rev. 2023 Jul;28(4):937-948. doi: 10.1007/s10741-022-10274-2. Epub 2022 Oct 3.
10
Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction.
Front Cardiovasc Med. 2021 Oct 29;8:656536. doi: 10.3389/fcvm.2021.656536. eCollection 2021.
本文引用的文献
1
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
2
Heart Failure With Preserved Ejection Fraction In Perspective.
Circ Res. 2019 May 24;124(11):1598-1617. doi: 10.1161/CIRCRESAHA.119.313572.
3
Risk of Heart Failure With Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer.
Circulation. 2017 Apr 11;135(15):1388-1396. doi: 10.1161/CIRCULATIONAHA.116.025434. Epub 2017 Jan 29.
4
Phenotypic spectrum of heart failure with preserved ejection fraction.
Heart Fail Clin. 2014 Jul;10(3):407-18. doi: 10.1016/j.hfc.2014.04.008. Epub 2014 May 22.
5
The many faces of heart failure with preserved ejection fraction.
Nat Rev Cardiol. 2012 Oct;9(10):555-6. doi: 10.1038/nrcardio.2012.123. Epub 2012 Sep 4.
Zotero 插件